Key facts
- Vantari (Healthcare Technology Systems)’s last known valuation is $12.3M (Sep 2023).
- It has raised $8.1M; the latest was Later Stage VC ($2.2M) in Nov 2025.
- Notable investors include Artesian, Acova Capital, Alliance of Angels, Australian Medical Angels, Barlong Investments Pty Ltd — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Vantari (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Vantari (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vantari (Healthcare Technology Systems)
Developer of a virtual reality training platform designed to simulate medical procedures for clinical practice. The company offers immersive procedure simulations, dynamic imaging capabilities, and a physics-based training environment, enabling healthcare professionals and medical institutions to enhance skills, reduce errors, and improve patient care outcomes.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2018
- Employees
- 18
- Website
- vantarivr.com/
- Ownership
- Privately Held (backing)
Vantari (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vantari (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vantari (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.